Lysosome-Targeting Chimeras as Clearing Agents for Pretargeted ImmunoSPECT

预定位 化学 体内分布 体内 离体 药理学 单克隆抗体 药代动力学 放射免疫疗法 MUC1号 抗体 放射性配体 生物物理学 谷氨酸羧肽酶Ⅱ 去唾液酸糖蛋白受体 免疫毒素 清理 体外 融合蛋白 细胞生物学
作者
Samantha Delaney,Charlotte Lund Denholt,Jacob Madsen,Andreas Kjær,Matthias M. Herth,Umberto Maria Battisti
出处
期刊:Bioconjugate Chemistry [American Chemical Society]
卷期号:37 (11): 2284-2293
标识
DOI:10.1021/acs.bioconjchem.6c00444
摘要

In vivo pretargeting based on the inverse electron-demand Diels-Alder reaction between a trans-cyclooctene (TCO)-modified monoclonal antibody (mAb) and a radiolabeled tetrazine (Tz) is a highly effective approach for reducing radiation burden in nuclear imaging and therapy. However, the large size and slow pharmacokinetics of full-length immunoglobulins greatly hinder their bloodstream clearance. To circumvent this limitation of pretargeting, much effort has been put towards developing masking or clearing agents: molecules designed to be injected prior to the radioligand to rid the bloodstream of excess circulating TCO-mAbs via clearance organs. Yet even with the use of previously established clearing agents, high levels of TCO-mAb still remain in circulation. Moreover, some of these agents could lead to aggregate formation in the lungs or clogs in the bloodstream. Recently, a novel class of cell-surface protein degraders called lysosome-targeting chimeras (LYTACs) have been reported to simultaneously bind hepatocytic-expressed asialoglycoprotein receptor (ASGPR) and a harmful, disease-relevant protein, internalizing the latter for lysosomal degradation. Herein, we present a novel ASGPR-targeted tetrazine-bearing LYTAC  TriGalNAc-Tz (LYTAC-Tz)  as a clearing agent for pretargeting. First, the essential components of the pretargeted system were synthesized: LYTAC-Tz, a TCO-modified variant of the mAb CC49 (TCO-CC49), and an 111In-labeled DOTA-bearing Tz ([111In]In-DOTA-Tz). Then, LYTAC-Tz was evaluated in vivo for its efficacy as a clearing agent for pretargeting in a murine model of colorectal cancer. SPECT-CT images and ex vivo biodistribution data revealed that LYTAC-Tz resulted in lower blood activity levels than control cohorts along with higher tumor-to-blood ratios. Healthy organs boasted low activity levels (excluding the kidneys, which showed uptake due to their rapid excretion of excess radioligand). Ultimately, this work illustrates that LYTAC-Tzs are effective clearing agents and could be beneficial for reducing radiotoxicity in pretargeted systems.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
香蕉觅云的应助被油菜的星星采纳,获得10
刚刚
北海发布了新的文献求助10
刚刚
王哈哈发布了新的文献求助10
刚刚
慕青的应助被zq采纳,获得10
1秒前
情怀的应助被细心小鸽子采纳,获得10
1秒前
Eva完成签到,获得积分10
1秒前
河洛之神完成签到,获得积分10
2秒前
2秒前
谷策完成签到,获得积分10
2秒前
3秒前
kkkkkkk完成签到,获得积分10
3秒前
3秒前
111完成签到,获得积分10
3秒前
一一完成签到,获得积分20
4秒前
风车车发布了新的文献求助20
5秒前
研友_VZG7GZ的应助被受伤白安采纳,获得10
5秒前
5秒前
Maple完成签到,获得积分10
5秒前
杨雨洁完成签到,获得积分10
6秒前
bkagyin的应助被研友_李开心采纳,获得10
6秒前
NexusExplorer的应助被阿希本希呀采纳,获得30
6秒前
lll完成签到,获得积分10
6秒前
bkagyin的应助被Demon采纳,获得10
7秒前
童宝完成签到,获得积分10
7秒前
7秒前
豆本豆发布了新的文献求助10
8秒前
9秒前
9秒前
10秒前
JJ完成签到 ,获得积分10
10秒前
科研通AI6.4的应助被感动苡采纳,获得10
11秒前
勤奋雨发布了新的文献求助10
11秒前
11秒前
员艳宁完成签到,获得积分10
12秒前
SciGPT的应助被7275XXX采纳,获得10
12秒前
13秒前
chenchen发布了新的文献求助10
13秒前
13秒前
穑1完成签到,获得积分10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8182352
求助须知:如何正确求助?哪些是违规求助? 9571930
关于积分的说明 21820825
捐赠科研通 7778861
什么是DOI,文献DOI怎么找? 3433657
关于科研通互助平台的介绍 2557824
邀请新用户注册赠送积分活动 2479703